SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001387131-16-004033
Filing Date
2016-02-01
Accepted
2016-02-01 12:56:46
Documents
6
Effectiveness Date
2016-02-01

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL MATERIALS ohr-defa14a_031716.htm DEFA14A 19670
2 GRAPHIC defa14a_img001.jpg GRAPHIC 1418
3 GRAPHIC defa14a_img002.jpg GRAPHIC 15875
4 GRAPHIC defa14a_img003.jpg GRAPHIC 1407
5 GRAPHIC defa14a_img004.jpg GRAPHIC 14984
6 GRAPHIC defa14a_img005.jpg GRAPHIC 1175
  Complete submission text file 0001387131-16-004033.txt   69054
Mailing Address 800 THIRD AVENUE 11TH FLOOR NEW YORK NY 10022
Business Address 800 THIRD AVENUE 11TH FLOOR NEW YORK NY 10022 (212) 682-8452
Ohr Pharmaceutical Inc (Filer) CIK: 0001173281 (see all company filings)

IRS No.: 465622433 | State of Incorp.: DE | Fiscal Year End: 0930
Type: DEFA14A | Act: 34 | File No.: 001-35963 | Film No.: 161376338
SIC: 2834 Pharmaceutical Preparations